News
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
6d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
“But once you optimize it for one organ, you can change out the mRNA with minimal optimization.” That adaptability is key. For example, Moderna recently made an updated version of its COVID-19 ...
The mRNA platform market holds significant opportunities, driven by advancements in LNP delivery systems, codon optimization, and synthetic biology tools like CRISPR-Cas9. These innovations support ...
K nowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions.
The DNA is basically a book of recipes. Each recipe tells the cells in our bodies how to make specific proteins by combining ...
In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...
A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...
Dr Wiklund added that mRNA vaccines require cold chain storage, so aren’t ideal for use in more difficult locations. He explained: “For more permanent pathogens, for example, polio or measles ...
Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example of cutting off one’s nose to spite one’s face. The latest science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results